Navin K. Chintala
- Oncology top 5%
- Immunology top 5%
- Molecular Biology
- Biomedical Engineering top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Prasad S. AdusumilliRachel GrosserLeonid CherkasskySurya Kumari VadrevuSharad SharmaMaciej M. MarkiewskiMagdalena KarbowniczekZachary E. Tano
- Topics
- CAR-T cell therapy research (17 papers)Cancer Immunotherapy and Biomarkers (6 papers)Immunotherapy and Immune Responses (4 papers)
- Cited by
- OncologyImmunologyBiotechnology
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Navin K. Chintala
23 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 850
- Immunology 620
- Molecular Biology 365
- Biomedical Engineering 255
- Pulmonary and Respiratory Medicine 186
Countries citing papers authored by Navin K. Chintala
This map shows the geographic impact of Navin K. Chintala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navin K. Chintala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navin K. Chintala more than expected).
Fields of papers citing papers by Navin K. Chintala
This network shows the impact of papers produced by Navin K. Chintala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navin K. Chintala. The network helps show where Navin K. Chintala may publish in the future.
Co-authorship network of co-authors of Navin K. Chintala
This figure shows the co-authorship network connecting the top 25 collaborators of Navin K. Chintala. A scholar is included among the top collaborators of Navin K. Chintala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navin K. Chintala. Navin K. Chintala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 16 | |
| 4 | 12 | |
| 5 | 0 | |
| 6 | 23 | |
| 7 | 23 | |
| 8 | 71 | |
| 9 | 2 | |
| 10 | 44 | |
| 11 | 9 | |
| 12 | Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumorsbreakdown → | 405 |
| 13 | 8 | |
| 14 | 4 | |
| 15 | 3 | |
| 16 | 101 | |
| 17 | 71 | |
| 18 | 4 | |
| 19 | 6 | |
| 20 | 161 |
About Navin K. Chintala
Navin K. Chintala is a scholar working on Oncology, Immunology and Biotechnology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (17 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (850 citations), Immunology (620 citations) and Biotechnology (59 citations). Navin K. Chintala has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Prasad S. Adusumilli, Rachel Grosser, Leonid Cherkassky, Surya Kumari Vadrevu, Sharad Sharma, Maciej M. Markiewski, Magdalena Karbowniczek, Zachary E. Tano, David P. Fairlie and Xiaoyu Li. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.